New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation
Thomas Daikeler(European Organisation for Rare Diseases), Vanderson Rocha(Université Paris Cité), Gèrard Socié(Hôpital Saint-Louis), Andrée-Laure Herr(European Organisation for Rare Diseases), Stefania Varotto, Jaime Sanz(Memorial Sloan Kettering Cancer Center), Myriam Labopin(Sorbonne Université), M. Akif Yeşilipek(Akdeniz University), Federica Sorà(Università Cattolica del Sacro Cuore), Éliane Gluckman(Université Paris Cité), Jérôme Cornillon(Institute Cancer De La Loire Lucien Neuwirth), Caroline A. Lindemans(University Medical Center Utrecht), Maura Faraci, José L. Díez‐Martín(Universidad Complutense de Madrid), Alessandro Crotta(European Organisation for Rare Diseases), Kristina Carlson(Uppsala University Hospital), Ajay Vora(Sheffield Children's Hospital), Virginie Gandemer, Annalisa Ruggeri(Inserm), Jan Voswinkel(Sorbonne Université), Anne O’Meara(Our Lady's Hospital), Mario Abinun(North Tyneside General Hospital), Petr Sedláček(University Hospital in Motol), Marleen Renard, Valérie Mialou(Institut d’Hématologie et d’Oncologie Pédiatrique), Anne Sîrvent(Hôpital l'Archet), Ayad Ahmed Hussein(King Hussein Cancer Center), Dominique Farge(Inserm)
Cited by 77
Related Papers
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859